These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 20928842)
1. Angiographic and intravascular ultrasound follow up of paclitaxel- and sirolimus-eluting stent after poststent high-pressure balloon dilation: from the poststent optimal stent expansion trial. Park SM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y; Kang WC; Ahn T; Kim BK; Oh SJ; Jeon DW; Yang JY Catheter Cardiovasc Interv; 2011 Jan; 77(1):15-21. PubMed ID: 20928842 [TBL] [Abstract][Full Text] [Related]
2. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555 [TBL] [Abstract][Full Text] [Related]
3. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193 [TBL] [Abstract][Full Text] [Related]
4. Effect of intravascular ultrasound-guided adjuvant high-pressure non-compliant balloon post-dilation after drug-eluting stent implantation. Muraoka Y; Sonoda S; Tsuda Y; Tanaka S; Okazaki M; Otsuji Y Heart Vessels; 2011 Nov; 26(6):565-71. PubMed ID: 21181171 [TBL] [Abstract][Full Text] [Related]
5. Decreased risk of stent fracture-related restenosis between paclitaxel-eluting stents and sirolimus eluting stents: results of long-term follow-up. Freixa X; Almasood AS; Khan SQ; Wainstein R; Osherov A; Mackie K; Seidelin PH; Džavík V Catheter Cardiovasc Interv; 2012 Mar; 79(4):559-65. PubMed ID: 21567881 [TBL] [Abstract][Full Text] [Related]
6. Intravascular ultrasound evaluation of optimal drug-eluting stent expansion after poststent balloon dilation using a noncompliant balloon versus a semicompliant balloon (from the Poststent Optimal Stent Expansion Trial [POET]). Kim JS; Moon JY; Ko YG; Choi D; Jang Y; Kang WC; Ahn T; Kim BK; Oh SJ; Jeon DW; Yang JY Am J Cardiol; 2008 Aug; 102(3):304-10. PubMed ID: 18638591 [TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717 [TBL] [Abstract][Full Text] [Related]
8. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ; JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548 [TBL] [Abstract][Full Text] [Related]
9. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study. Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095 [TBL] [Abstract][Full Text] [Related]
10. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents. Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J; J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863 [TBL] [Abstract][Full Text] [Related]
11. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial. Kume T; Waseda K; Koo BK; Yock PG; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Honda Y; Abizaid A; Fitzgerald PJ Catheter Cardiovasc Interv; 2014 Jan; 83(1):19-24. PubMed ID: 23413202 [TBL] [Abstract][Full Text] [Related]
12. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent. Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247 [TBL] [Abstract][Full Text] [Related]
13. Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer. Byrne RA; Iijima R; Mehilli J; Pinieck S; Bruskina O; Schömig A; Kastrati A JACC Cardiovasc Interv; 2009 Apr; 2(4):291-9. PubMed ID: 19463439 [TBL] [Abstract][Full Text] [Related]
14. Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis. Xu B; Qian J; Ge J; Wang J; Chen F; Chen J; Wei M; Chen Y; Yang Y; Gao R; Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():624-9. PubMed ID: 26775079 [TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses. Sakata K; Waseda K; Kume T; Otake H; Nakatani D; Yock PG; Fitzgerald PJ; Honda Y Circ Cardiovasc Interv; 2012 Dec; 5(6):763-71. PubMed ID: 23149332 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of sirolimus-eluting stents vs. paclitaxel-eluting stents in unprotected left main coronary artery bifurcation lesions. Song PS; Ryu DR; Song YB; Hahn JY; Choi JH; Choi SH; Lee SH; Hong KP; Park JE; Gwon HC Clin Cardiol; 2011 Jun; 34(6):378-83. PubMed ID: 21538383 [TBL] [Abstract][Full Text] [Related]
17. Crush stenting with paclitaxel-eluting or sirolimus-eluting stents for the treatment of coronary bifurcation lesions. Chen S; Zhang J; Ye F; Zhu Z; Lin S; Tian N; Liu Z; Fang W; Chen Y; Sun X; Kwan TW Angiology; 2008; 59(4):475-83. PubMed ID: 18388098 [TBL] [Abstract][Full Text] [Related]
18. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions. Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study. Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728 [TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus: 4-year clinical outcomes of DES-DIABETES (drug-eluting stent in patients with DIABETES mellitus) trial. Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Kim HS; Park SJ JACC Cardiovasc Interv; 2011 Mar; 4(3):310-6. PubMed ID: 21435609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]